• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE TAXUS® LIBERTÉ®; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE TAXUS® LIBERTÉ®; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493893612300
Device Problem Occlusion Within Device (1423)
Patient Problems Chest Pain (1776); Myocardial Infarction (1969); Nausea (1970); Thrombosis (2100); Diaphoresis (2452)
Event Date 01/19/2014
Event Type  Injury  
Event Description
Same case as mdr id: 2134265-2014-01538.(b)(4).It was reported that stent thrombosis, substernal chest pain associated with diaphoresis and nausea occurred.On (b)(6) 2010, the patient presented with 4 months history of mild chest pain associated with left sided jaw pain and was diagnosed with stable angina.Cardiac catheterization was recommended.Subsequently, coronary angiography and index procedure was performed.Target lesion #1 was a denovo lesion located in the mid left anterior descending (lad) with 99% stenosis and was 8 mm long with a reference vessel diameter of 3.0 mm.Target lesion #1 was treated with direct stent placement using a 3.50 x 12 mm taxus liberté stent.Following post dilatation residual stenosis was 0%.Target lesion #2 was a denovo lesion located in the proximal lad with 75-80% stenosis and was 8 mm long with a reference vessel diameter of 3.5 mm.Target lesion#2 was treated with direct stent placement using a 3.50 x 12 mm taxus liberté stent.Following post dilatation, residual stenosis was 0%.One day post procedure, the patient was discharged on aspirin and prasugrel.On (b)(6) 2014, the patient presented with episodes of sudden substernal crushing chest pain associated with diaphoresis and nausea and patient was hospitalized immediately.Electrocardiogram (ecg) changes were indicative of ischemia.Troponin was drawn however value is unknown.At the time of the event, the subject was on aspirin only.The study drug per protocol was never taken during the study and other anti-platelet medication was last taken on (b)(6) 2014.The patient was diagnosed with non-st elevation myocardial infarction on the following day and cardiac catheterization was recommended.Then two days from admission, coronary angiography revealed stent thrombosis in proximal lad and filling defect associated with proximal lad.The patient was treated medically.Two days from admission, the event was considered to be resolved without residual effects and the patient was discharged on aspirin and clopidogrel.
 
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Manufacturer Narrative
Describe event or problem-corrected and updated.(b)(4).
 
Event Description
It further reported that the study stent implanted in mid lad was 3.00x12 taxus liberte stent and not 3.5x12 taxus liberte stent as previously reported.The stent thrombosis was noted in proximal lad extending to mid lad.In addition, angiography without revascularization was performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TAXUS® LIBERTÉ®
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer Contact
ingrid matte
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key3723008
MDR Text Key4234988
Report Number2134265-2014-01966
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/24/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/29/2011
Device Model NumberH7493893612300
Device Catalogue Number38936-1230
Device Lot Number12923052
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/29/2014
Initial Date FDA Received04/02/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/22/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/14/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age44 YR
-
-